Clinical Trial: A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) .

U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07483268) titled 'A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) .' on March 16.

Brief Summary: This study is a open label, prospective study to evaluate the safety of Stapokibart Injection in subjects with CRSwNP.

Study Start Date: June, 2026

Study Type: OBSERVATIONAL

Condition: CRSWNP

Intervention: BIOLOGICAL: Stapokibart

subcutaneous injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Chengdu Kangnuoxing Biopharma,Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....